NCT07228611

Brief Summary

The aim of this study is to evaluate the effect of these factors and stroke itself on osteoporosis developing after stroke. Thus, the expected benefit of the study is to contribute to the identification and determination of the need for treatment in high-risk patients through further studies. There are no expected risks from the study.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
84

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Dec 2025

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 13, 2025

Completed
1 day until next milestone

First Posted

Study publicly available on registry

November 14, 2025

Completed
21 days until next milestone

Study Start

First participant enrolled

December 5, 2025

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2026

Completed
Last Updated

February 24, 2026

Status Verified

November 1, 2025

Enrollment Period

5 months

First QC Date

November 13, 2025

Last Update Submit

February 22, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Bone Mineral Density

    First day of hospitalization

Secondary Outcomes (7)

  • Brunnstrom

    First day of hospitalization

  • Modified Barthel Index

    First day of hospitalization

  • Modified Ashworth Scale

    First day of hospitalization

  • Modified Fall Impact Scale

    First day of hospitalization

  • Vitamin D, prealbumin, and albumin

    First day of hospitalization

  • +2 more secondary outcomes

Study Arms (3)

Subacute Stroke

Diagnostic Test: Bone Mineral Density

Chronic Stroke

Diagnostic Test: Bone Mineral Density

Healthy Volunteer

Diagnostic Test: Bone Mineral Density

Interventions

Bone Mineral DensityDIAGNOSTIC_TEST

Patients who have had a stroke and are at risk of fracture, and for whom routine assessment requires Bone Mineral Density (BMD) testing, will be included in the study. In addition, patients who have already undergone BMD testing for osteoporosis screening and who present to the outpatient clinic, with similar age and comorbidities, will be screened from the system, and 28 non-stroke patients who agree to participate will be included in the study.

Chronic StrokeHealthy VolunteerSubacute Stroke

Eligibility Criteria

Age55 Years - 85 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Fifty-six stroke patients receiving inpatient treatment will be evaluated. In addition, patients who have visited the outpatient clinic and have already undergone BMD scanning for osteoporosis screening, with similar age and comorbidities, will be screened from the system, and 28 non-stroke patients who agree to participate will be randomly included in the study.

You may qualify if:

  • Followed by ischemic or hemorrhagic stroke
  • Between 1 week and 6 months or \>1 year has passed since the date of the event
  • Being between 55 and 85 years of age

You may not qualify if:

  • The patient has additional neurological conditions besides stroke
  • The patient has a psychiatric condition
  • History of recurrent stroke
  • BMD scan performed within the last year for stroke patients
  • Having received osteoporosis treatment before or after the stroke
  • The patient having a fragility fracture before the stroke
  • The patient having a hip fracture or hip prosthesis
  • The patient having an additional condition that affects physical function before the stroke (amputation, severe fracture)
  • The patient has an additional disease or medication use that could cause secondary osteoporosis
  • The patient's stroke did not cause physical function loss

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ankara Etlik City Hospital

Ankara, Yenimahalle, 06010, Turkey (Türkiye)

RECRUITING

MeSH Terms

Interventions

Bone Density

Intervention Hierarchy (Ancestors)

Musculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Central Study Contacts

Ayşe Naz Kalem Özgen, specialist

CONTACT

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER GOV
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
PM&R Specialist

Study Record Dates

First Submitted

November 13, 2025

First Posted

November 14, 2025

Study Start

December 5, 2025

Primary Completion

May 1, 2026

Study Completion

May 1, 2026

Last Updated

February 24, 2026

Record last verified: 2025-11

Locations